News | FDA | December 09, 2025

Remington Medical’s Bluetooth-Enabled, Cordless Doppler Gets FDA Clearance

The VascuCheck 2.0 handheld device adds optional external speaker for louder, clearer audio.

Remington Medical’s Bluetooth-Enabled, Cordless Doppler Gets FDA Clearance

Photo: Getty Images


Nov. 25, 2025 — Remington Medical has received U.S. Food and Drug Administration (FDA) 510(k) clearance and announced the commercial launch of the second-generation VascuChek Doppler. VascuChek is a handheld vascular Doppler device for clinical and surgical use. With the addition of a Bluetooth external speaker, VascuChek 2.0 gives clinicians and surgeons superior audio clarity and volume to more accurately assess patients’ blood flow during surgeries.

The second-generation VascuChek builds upon the first-gen device’s features with the same convenient handheld control and cordless freedom for monitoring vascular flow. The kit consists of a handheld transceiver and a detachable, disposable probe (both surgical and clinical variants). The probe attaches to the transceiver similar to how the brush head of an electric toothbrush connects with the handle.

Its single-use probes with patented antiseptic sheath make VascuChek the only wireless, handheld Doppler device that has been FDA-cleared for evaluating intraoperative and subcutaneous blood flow in a sterile field during surgery.

VascuChek has two internal speakers for real-time audio feedback when assessing a patient’s blood flow. If necessary, users can toggle the audio to the Bluetooth speaker built into the device’s charging base to provide improved clarity and volume.

“When it launched in 2022, VascuChek was a big leap forward for convenience and ease, offering surgeons a cordless Doppler that gave them full control,” said Attly Aycock, CEO of Remington Medical. “The new device builds on that and adds even better audio clarity and volume; we made these updates based on valuable feedback from surgeons who’ve been using VascuChek in their ORs. We’re confident that VascuChek can transform operational efficiencies for the more than 38,000 operating rooms across the U.S.”

Primary users of VascuChek include vascular, cardiac, orthopedic, podiatry and general surgeons, cardiologists and surgical nurses. VascuChek is currently available for sale within the U.S.

For inquiries about VascuChek, or to schedule a product demonstration, please visit https://vascuchek.com/contact/


Related Content

News | Cath Lab

May 13, 2026 — According to a recently released report, the global cath lab services market was valued at $46.0 billion ...

Home May 13, 2026
Home
News | Cath Lab

April 16, 2026 — A national study led by investigators from Cedars-Sinai Health Sciences University found that ...

Home April 20, 2026
Home
News | Cath Lab

April 6, 2026 —Stereotaxis has received U.S. Food and Drug Administration 510(k) clearance for its Synchrony system ...

Home April 07, 2026
Home
News | Cath Lab

March 31, 2026 — Solo Pace Inc. has announced the commercial release of the SoloPace Fusion Temporary Pacing System. The ...

Home April 03, 2026
Home
News | Cath Lab

March 25, 2026 — Royal Philips has launched its intuitive interventional guidance platform, IntraSight Plus, which is ...

Home March 26, 2026
Home
Feature | Cath Lab | Kyle Hardner

Since receiving FDA approval in 2016, intravascular lithotripsy (IVL) systems have grown in popularity among ...

Home November 14, 2025
Home
News | Cath Lab

Nov. 11, 2025 — FastWave Medical has successfully completed enrollment in its 30-patient coronary feasibility study and ...

Home November 13, 2025
Home
News | Cath Lab

Oct. 28, 2025 — Results from the first-of-its-kind randomized PROCTOR trial found that a strategy of saphenous vein ...

Home November 04, 2025
Home
News | Cath Lab

Oct. 27, 2025 — Results from the PREVUE-VALVE study suggest that there are currently at least 4.7 million people aged 65 ...

Home October 29, 2025
Home
News | Cath Lab

Oct. 25, 2025 — Medtronic plc has announced the launch of the Stedi Extra Support guidewire, designed to enhance ...

Home October 28, 2025
Home
Subscribe Now